OBJECTIVE: To evaluate the role of self-efficacy, anticipated negative consequences, and relationship quality in patient-initiated sex partner notification following treatment for sexually transmitted infections. SUBJECTS: Two hundred forty-one 13- to 20-year-old subjects (83% women; 83% African American) diagnosed with gonorrhea, chlamydia, trichomonas, or nongonococcal urethritis. Subjects were patients at a public sexually transmitted diseases clinic or primary care adolescent clinics. METHODS: Structured interviews at enrollment and 1 month following treatment. At enrollment, recent sexual partners were identified. Coital frequency, partner-specific sexually transmitted infection notification self-efficacy, anticipated consequences of notification, and relationship quality were measured with multi-item scales. At 1 month, subjects were asked whether partners had been notified and about the timing of notification relative to treatment. RESULTS: Subjects reported 279 partners. Of these, 61% of women's partners and 52% of men's partners were notified. Multiple logistic regression adjusted by generalized estimating equations showed that notification was predicted by antecedent notification self-efficacy (adjusted odds ratio, 1.16; 95% confidence interval, 1.03-1.30) and relationship quality (adjusted odds ratio, 1.17; 95% confidence interval, 1.08-1.27). Age, sex, race/ethnicity, prior sexually transmitted infection, coital frequency, and anticipated consequences were not related to partner notification. CONCLUSIONS: Partner notification is increased among persons with higher levels of self-efficacy and in relationships with stronger affiliative and emotional ties. Self-efficacy and partner communication could be especially amenable to interventions to increase patient-initiated partner notification for curable sexually transmitted infections.
OBJECTIVE: To evaluate the role of self-efficacy, anticipated negative consequences, and relationship quality in patient-initiated sex partner notification following treatment for sexually transmitted infections. SUBJECTS: Two hundred forty-one 13- to 20-year-old subjects (83% women; 83% African American) diagnosed with gonorrhea, chlamydia, trichomonas, or nongonococcal urethritis. Subjects were patients at a public sexually transmitted diseases clinic or primary care adolescent clinics. METHODS: Structured interviews at enrollment and 1 month following treatment. At enrollment, recent sexual partners were identified. Coital frequency, partner-specific sexually transmitted infection notification self-efficacy, anticipated consequences of notification, and relationship quality were measured with multi-item scales. At 1 month, subjects were asked whether partners had been notified and about the timing of notification relative to treatment. RESULTS: Subjects reported 279 partners. Of these, 61% of women's partners and 52% of men's partners were notified. Multiple logistic regression adjusted by generalized estimating equations showed that notification was predicted by antecedent notification self-efficacy (adjusted odds ratio, 1.16; 95% confidence interval, 1.03-1.30) and relationship quality (adjusted odds ratio, 1.17; 95% confidence interval, 1.08-1.27). Age, sex, race/ethnicity, prior sexually transmitted infection, coital frequency, and anticipated consequences were not related to partner notification. CONCLUSIONS: Partner notification is increased among persons with higher levels of self-efficacy and in relationships with stronger affiliative and emotional ties. Self-efficacy and partner communication could be especially amenable to interventions to increase patient-initiated partner notification for curable sexually transmitted infections.
Authors: Rebecca M Schwartz; Edmond S Malka; Michael Augenbraun; Steven Rubin; Matthew Hogben; Nicole Liddon; William M McCormack; Tracey E Wilson Journal: J Urban Health Date: 2006-11 Impact factor: 3.671
Authors: Yuzo Arima; Rachel L Winer; Ann E Kurth; Diane P Martin; James P Hughes; Michael E Stern; Qinghua Feng; Nancy B Kiviat; Laura A Koutsky Journal: Sex Transm Dis Date: 2012-08 Impact factor: 2.830
Authors: Catherine H Mercer; Catherine R H Aicken; M Gary Brook; Claudia S Estcourt; Jackie A Cassell Journal: Am J Public Health Date: 2011-09-22 Impact factor: 9.308
Authors: Jacob J van den Berg; Marjan Javanbakht; Pamina M Gorbach; Bret J Rudy; Andrew O Westfall; Craig M Wilson; Michelle A Lally Journal: J Acquir Immune Defic Syndr Date: 2018-01-01 Impact factor: 3.731
Authors: S L Rosenthal; G D Zimet; J S Leichliter; L R Stanberry; K H Fife; W Tu; D I Bernstein Journal: Sex Transm Infect Date: 2006-04 Impact factor: 3.519
Authors: Gina M Secura; Fidel A Desir; Jennifer L Mullersman; Tessa Madden; Jenifer E Allsworth; Jeffrey F Peipert Journal: Sex Transm Dis Date: 2012-10 Impact factor: 2.830
Authors: Richard L Skolasky; Lee H Riley; Anica M Maggard; Saaniya Bedi; Stephen T Wegener Journal: Contemp Clin Trials Date: 2013-06-29 Impact factor: 2.226
Authors: Hannan M Braun; Eddy R Segura; Jordan E Lake; Monica Gandhi; Jessica Rios; Manuel V Villaran; Jorge Sanchez; Javier R Lama; Jesse L Clark Journal: Sex Transm Infect Date: 2017-11-30 Impact factor: 3.519